X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with SHASUN PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA SHASUN PHARMA NATCO PHARMA/
SHASUN PHARMA
 
P/E (TTM) x 34.8 123.9 28.1% View Chart
P/BV x 17.7 8.5 207.6% View Chart
Dividend Yield % 0.6 0.2 277.1%  

Financials

 NATCO PHARMA   SHASUN PHARMA
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
SHASUN PHARMA
Mar-14
NATCO PHARMA/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs87794 931.0%   
Low Rs42446 928.7%   
Sales per share (Unadj.) Rs223.4214.2 104.3%  
Earnings per share (Unadj.) Rs31.15.3 582.2%  
Cash flow per share (Unadj.) Rs40.315.8 254.6%  
Dividends per share (Unadj.) Rs5.001.00 500.0%  
Dividend yield (eoy) %0.81.4 53.7%  
Book value per share (Unadj.) Rs219.553.3 411.5%  
Shares outstanding (eoy) m33.0756.62 58.4%   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.90.3 891.7%   
Avg P/E ratio x20.913.1 159.8%  
P/CF ratio (eoy) x16.14.4 365.4%  
Price / Book Value ratio x3.01.3 226.1%  
Dividend payout %16.118.7 85.9%   
Avg Mkt Cap Rs m21,5043,958 543.3%   
No. of employees `000NANA-   
Total wages/salary Rs m1,1282,164 52.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m7,38912,127 60.9%  
Other income Rs m167229 72.9%   
Total revenues Rs m7,55612,356 61.2%   
Gross profit Rs m1,7931,009 177.7%  
Depreciation Rs m304594 51.3%   
Interest Rs m366415 88.2%   
Profit before tax Rs m1,290230 561.5%   
Minority Interest Rs m460-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m309-73 -424.5%   
Profit after tax Rs m1,027302 340.1%  
Gross profit margin %24.38.3 291.7%  
Effective tax rate %23.9-31.7 -75.6%   
Net profit margin %13.92.5 558.1%  
BALANCE SHEET DATA
Current assets Rs m3,6816,884 53.5%   
Current liabilities Rs m3,1238,456 36.9%   
Net working cap to sales %7.6-13.0 -58.3%  
Current ratio x1.20.8 144.8%  
Inventory Days Days8962 145.2%  
Debtors Days Days59108 54.6%  
Net fixed assets Rs m7,6854,970 154.6%   
Share capital Rs m331113 291.9%   
"Free" reserves Rs m6,6702,875 232.0%   
Net worth Rs m7,2593,020 240.3%   
Long term debt Rs m9551,817 52.5%   
Total assets Rs m11,95713,347 89.6%  
Interest coverage x4.51.6 291.1%   
Debt to equity ratio x0.10.6 21.9%  
Sales to assets ratio x0.60.9 68.0%   
Return on assets %11.75.4 216.9%  
Return on equity %14.210.0 141.5%  
Return on capital %20.713.3 155.6%  
Exports to sales %39.446.4 84.9%   
Imports to sales %5.714.2 40.0%   
Exports (fob) Rs m2,9085,622 51.7%   
Imports (cif) Rs m4211,728 24.4%   
Fx inflow Rs m3,4455,843 59.0%   
Fx outflow Rs m7032,173 32.3%   
Net fx Rs m2,7433,669 74.7%   
CASH FLOW
From Operations Rs m1,440398 362.2%  
From Investments Rs m-1,089-1,635 66.6%  
From Financial Activity Rs m-3531,309 -27.0%  
Net Cashflow Rs m-171 -2.1%  

Share Holding

Indian Promoters % 52.0 39.2 132.8%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 3.6 217.8%  
FIIs % 16.6 17.6 94.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 39.6 65.7%  
Shareholders   25,395 20,750 122.4%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare NATCO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Infosys Surges 3% on Buyback News(09:30 am)

Majority of Asian stock indices are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.26% while the Hang Seng is up 0.05%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 17, 2017 10:02 AM

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - PANACEA BIOTECH COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS